Titan Pharmaceuticals Overhauls Leadership, Settles with Ex-Directors
Company Announcements

Titan Pharmaceuticals Overhauls Leadership, Settles with Ex-Directors

Titan Pharmaceuticals (TTNP) has issued an announcement.

Titan Pharmaceuticals, Inc. has finalized a Settlement Agreement and General and Mutual Release with former directors Eric Greenberg, Matthew C. McMurdo, and David Natan following their resignations. This development marks a significant change in the company’s leadership dynamics and could be of interest to shareholders monitoring corporate governance and strategic direction shifts.

For a thorough assessment of TTNP stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App